Menu

Blog

Jan 30, 2019

For the January Journal Club, we will be taking a look at the recent human senolytics trial conducted at the Mayo Clinic

Posted by in category: biotech/medical

Literature

Justice, J. N., Nambiar, A. M., Tchkonia, T., LeBrasseur, N. K., Pascual, R., Hashmi, S. K., … & Kirkland, J. L. (2019). Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine.

Read more

0 comments

Comments are closed.

Tag cloud

aging AI Alzheimer's anti-aging Artificial Intelligence bioquantine bioquark biotech biotechnology bitcoin blockchain brain death cancer cryptocurrency culture Death existential risks extinction future futurism Google health healthspan humanity ideaxme immortality Interstellar Travel ira pastor Life extension lifespan longevity NASA Neuroscience politics reanima regenerage regeneration research risks singularity space sustainability technology transhumanism wellness

Categories